期刊
CELL REPORTS
卷 36, 期 7, 页码 -出版社
CELL PRESS
DOI: 10.1016/j.celrep.2021.109547
关键词
-
类别
资金
- National Institutes of Health (NIH) [P20 GM104936, R01DK115850, R35GM119528, T32DK071496]
- Northwestern University George M. O'Brien Kidney Research Core Center [P30 DK114857]
The study found that hypoxic preconditioning and PHD inhibition increase serum kynurenine levels, protecting the kidney from damage. The IDO1-kynurenine axis plays a critical role in mediating hypoxic preconditioning.
Prolonged cellular hypoxia leads to energetic failure and death. However, sublethal hypoxia can trigger an adaptive response called hypoxic preconditioning. While prolyl-hydroxylase (PHD) enzymes and hypoxiainducible factors (HIFs) have been identified as key elements of oxygen-sensing machinery, themechanisms by which hypoxic preconditioning protects against insults remain unclear. Here, we perform serum metabolomic profiling to assess alterations induced by two potent cytoprotective approaches, hypoxic preconditioning and pharmacologic PHD inhibition. We discover that both approaches increase serum kynurenine levels and enhance kynurenine biotransformation, leading to preservation of NAD(+) in the post-ischemic kidney. Furthermore, we show that indoleamine 2,3-dioxygenase 1 (Ido1) deficiency abolishes the systemic increase of kynurenine and the subsequent renoprotection generated by hypoxic preconditioning and PHD inhibition. Importantly, exogenous administration of kynurenine restores the hypoxic preconditioning in the context of Ido1 deficiency. Collectively, our findings demonstrate a critical role of the IDO1-kynurenine axis in mediating hypoxic preconditioning.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据